Evidence map›Paper›PMID 35352769›Full record

ArticleEinstein (Sao Paulo, Brazil)2022

Fast growth rate of a right atrial myxoma.

Douglas Mesadri Gewehr, Alan Neiverth, Marcela Santos Cavalcanti, Thiago Ceschin Maestri, Semi Haurani, Fernando Bermudez Kubrusly, Luiz Fernando Kubrusly

Abstract readCase Reports
In one paragraph

Article in Einstein (Sao Paulo, Brazil), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. An uncommon case of a rapidly growing intracardiac mass.Global cardiology science & practice · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Douglas Mesadri GewehrFaculdade Evangélica Mackenzie do Paraná , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0001-9393-2445
Alan NeiverthFaculdade Evangélica Mackenzie do Paraná , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0002-6926-1431
Marcela Santos CavalcantiNeopath Patologia Diagnóstica , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0001-9858-1509
Thiago Ceschin MaestriFaculdade Evangélica Mackenzie do Paraná , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0002-5561-9877
Semi HauraniUnidade de Cardiologia , Centro de Prevenção e Recuperação de Vidas Ltda , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0003-0691-3794
Fernando Bermudez KubruslyInstituto Denton Cooley de Pesquisa, Ciência e Tecnologia , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0002-5045-9237
Luiz Fernando KubruslyFaculdade Evangélica Mackenzie do Paraná , Curitiba , PR , Brazil .ORCID http://orcid.org/0000-0002-6546-9841

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cardiac tumors are rare, with an incidence between 0.0017 and 0.19%, and are asymptomatic in up to 72% of cases. Approximately 75% of tumors are benign, and nearly 50% of these are myxomas. Concerning location, 75% of myxomas are in the left atrium, 15 to 20% in the right atrium, and more rarely in the ventricles. The finding of cardiac myxomas usually implies immediate surgical excision to prevent embolic events and sudden cardiac death. Reports with documented growth rate are rare, and the actual growth rate remains a controversial issue. We report the rapid growth rate of a right atrial myxoma in an oligosymptomatic 69-year-old patient, with negative previous echocardiographic history in the last two years, who refused surgery upon diagnosis, enabling monitoring of myxoma growth.

Indexed as

Heart NeoplasmsMyxomaAgedEchocardiographyHeart AtriaHumansIncidence

Identifiers

PMID35352769
PMCPMC8932729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.